Iotrolan
![Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set](http://data.docslib.org/img/264x/135084d885a0ce0d8ef8f9f83426c79a.webp)
Top View
- (12) Patent Application Publication (10) Pub. No.: US 2011/0269704 A1 Seigfried (43) Pub
- Diagnostic Evaluation of Patients with Nonimmediate Cutaneous Hypersensitivity Reactions to Iodinated Contrast Media M
- A Primer on Parenteral Radiopaque Contrast Agents
- Food and Drugs Regulations, 1975
- (12) Patent Application Publication (10) Pub. No.: US 2011/0052503 A1 Almen Et Al
- Examination of Patients Suspected As Having Hypersensitivity to Iodinated
- ATC-Index Mit DDD-Angaben Für Den Deutschen Arzneimittelmarkt Berlin 2013, 12
- United States Patent 1191 [11] Patent Number: 5,686,061 Li Et Al
- Aseptic Meningitis Complicating Lotrolan Myelography
- Aseptic Meningoencephalitis After Iohexol CT Myelography
- ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2019
- XENETIX Mono
- Total Organic Halogen Formation in the Presence Of
- (12) Patent (19) Australian Patent Office
- Injection of Low and Iso-Osmolar Contrast Medium Decreases Oxygen Tension in the Renal Medulla
- Radiographic Contrast Media: a New Risk for Pulmonary Aspiration ?
- Pharmacology, Part 5: CT and MRI Contrast Media
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances